> Typhoid fever vaccine
Typhoid fever vaccine
Novartis Vaccines Institute for Global Health – novel conjugated vaccine
Implementation and development of cGMP production process for a novel conjugated vaccine for Salmonella typhimurium.

GenIbet has a collaboration with the Novartis Vaccines Institute for Global Health (NVGH), a research institute established by Novartis and dedicated to the translational research and development of vaccines for developing countries. NVGH has a not-for-profit mission to develop effective and affordable vaccines for neglected infectious diseases in developing countries. Within the framework of this collaboration we have recently produced a cGMP clinical batch for phase I trials of a novel conjugated typhoid fever vaccine.

Powered by: